The use of oxytocin and relaxin in the treatment of refractory chronic pain with mixed characteristics (neuropathic and myofascial pain). Case report

Isadora Cerruti Guarnieri, D. P. Rodrigues, K. Ferreira
{"title":"The use of oxytocin and relaxin in the treatment of refractory chronic pain with mixed characteristics (neuropathic and myofascial pain). Case report","authors":"Isadora Cerruti Guarnieri, D. P. Rodrigues, K. Ferreira","doi":"10.5935/1806-0013.20170130","DOIUrl":null,"url":null,"abstract":"BACKGROUND AND OBJECTIVES : Some studies have related the use of synthetic oxytocin for the treatment of painful syndromes that relies on central and peripheral modulation mechanisms of pain. Thus, the objective of this study was to report a case of a patient with a refractory chronic pain of mixed characteristics (myofascial and neuropathic pain) who responded to the treatment with synthetic oxytocin and relaxin. CASE REPORT : Female patient, 41 years old, presenting a 10-year history of right hemifacial pain after dental surgery, with neuropathic characteristics, diagnosed as atypical facial pain (atypical trigeminal neuralgia). Later, she developed pain in the right cervical region, radiating to the shoulder, with several muscle trigger points in the pericranial region, suggestive of myofascial pain. After treatment with antidepressants, neuromodula-tors, anesthetic blockade, capsaicin and topical lidocaine, with partial results and pain recurrence, she started treatment with intramuscular oxytocin and oral relaxin. Over the year she fol-lowed the proposed treatment, she presented light pain, greater pain-free intervals, reduced need of pain blockade, improved tolerance to physical exercise and of the local face allodynia. CONCLUSION : Despite the new drugs, procedures, and protocols to treat chronic pain, the patients often present unsatisfactory outcomes. Many times, there are situations of mixed pain (neuropathic and myofascial pain) with central and peripheral sensitization, resulting in worse prognostic and refractoriness. In this case, synthetic oxytocin and relaxin presented a satisfactory response.","PeriodicalId":30846,"journal":{"name":"Revista Dor","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista Dor","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5935/1806-0013.20170130","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

BACKGROUND AND OBJECTIVES : Some studies have related the use of synthetic oxytocin for the treatment of painful syndromes that relies on central and peripheral modulation mechanisms of pain. Thus, the objective of this study was to report a case of a patient with a refractory chronic pain of mixed characteristics (myofascial and neuropathic pain) who responded to the treatment with synthetic oxytocin and relaxin. CASE REPORT : Female patient, 41 years old, presenting a 10-year history of right hemifacial pain after dental surgery, with neuropathic characteristics, diagnosed as atypical facial pain (atypical trigeminal neuralgia). Later, she developed pain in the right cervical region, radiating to the shoulder, with several muscle trigger points in the pericranial region, suggestive of myofascial pain. After treatment with antidepressants, neuromodula-tors, anesthetic blockade, capsaicin and topical lidocaine, with partial results and pain recurrence, she started treatment with intramuscular oxytocin and oral relaxin. Over the year she fol-lowed the proposed treatment, she presented light pain, greater pain-free intervals, reduced need of pain blockade, improved tolerance to physical exercise and of the local face allodynia. CONCLUSION : Despite the new drugs, procedures, and protocols to treat chronic pain, the patients often present unsatisfactory outcomes. Many times, there are situations of mixed pain (neuropathic and myofascial pain) with central and peripheral sensitization, resulting in worse prognostic and refractoriness. In this case, synthetic oxytocin and relaxin presented a satisfactory response.
使用催产素和松弛素治疗难治性慢性疼痛混合特征(神经性和肌筋膜疼痛)。病例报告
背景和目的:一些研究表明,使用合成催产素治疗依赖于疼痛中枢和外周调节机制的疼痛综合征。因此,本研究的目的是报告一例具有混合特征(肌筋膜和神经性疼痛)的难治性慢性疼痛患者,该患者对合成催产素和松弛素的治疗有反应。病例报告:女性患者,41岁,牙科手术后有10年右半面部疼痛史,具有神经病理性特征,诊断为非典型面部疼痛(非典型三叉神经痛)。后来,她出现了右侧颈部疼痛,辐射到肩部,颅周区域有几个肌肉触发点,提示肌筋膜疼痛。在使用抗抑郁药、神经调节剂、麻醉剂阻断剂、辣椒素和局部利多卡因进行治疗后,部分结果和疼痛复发,她开始使用肌内催产素和口服松弛素进行治疗。在接受拟议治疗的一年里,她出现了轻微疼痛、更大的无疼痛间隔、减少了对疼痛阻断的需要、提高了对体育锻炼的耐受性和局部面部异常疼痛。结论:尽管有新的药物、程序和方案来治疗慢性疼痛,但患者往往表现出不令人满意的结果。很多时候,会出现中枢和外周致敏的混合性疼痛(神经性和肌筋膜疼痛),导致更差的预后和难治性。在这种情况下,合成催产素和松弛素呈现出令人满意的反应。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
审稿时长
15 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信